Takuya Saito

NPI: 1659762060
Total Payments
$75,944
2024 Payments
$6,622
Companies
3
Transactions
128

Payment Breakdown by Category

Consulting$51,665 (68.0%)
Other$15,635 (20.6%)
Travel$8,254 (10.9%)
Food & Beverage$390.00 (0.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $51,665 46 68.0%
Honoraria $11,919 13 15.7%
Travel and Lodging $8,254 46 10.9%
Compensation for serving as faculty or as a speaker for a medical education program $3,717 4 4.9%
Food and Beverage $390.00 19 0.5%

Top Paying Companies

Company Total Records Latest Year
Sumitomo Dainippon Pharma Co., Ltd. $42,750 75 $0 (2021)
Sumitomo Pharma Co., Ltd. $26,162 44 $0 (2024)
Shionogi Inc $7,032 9 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $6,622 10 Sumitomo Pharma Co., Ltd. ($6,622)
2023 $7,997 13 Sumitomo Pharma Co., Ltd. ($7,997)
2022 $12,442 23 Sumitomo Pharma Co., Ltd. ($11,543)
2021 $18,262 32 Sumitomo Dainippon Pharma Co., Ltd. ($14,923)
2020 $8,963 9 Sumitomo Dainippon Pharma Co., Ltd. ($6,168)
2019 $6,154 5 Sumitomo Dainippon Pharma Co., Ltd. ($6,154)
2018 $9,087 24 Sumitomo Dainippon Pharma Co., Ltd. ($9,087)
2017 $6,418 12 Sumitomo Dainippon Pharma Co., Ltd. ($6,418)

All Payment Transactions

128 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
11/29/2024 Sumitomo Pharma Co., Ltd. Latuda (Drug) Consulting Fee Cash or cash equivalent $1,136.25 General
Category: CNS
08/30/2024 Sumitomo Pharma Co., Ltd. Latuda (Drug) Consulting Fee Cash or cash equivalent $1,163.81 General
Category: CNS
05/31/2024 Sumitomo Pharma Co., Ltd. Latuda (Drug) Consulting Fee Cash or cash equivalent $1,081.97 General
Category: CNS
02/29/2024 Sumitomo Pharma Co., Ltd. Latuda (Drug) Consulting Fee Cash or cash equivalent $1,133.53 General
Category: CNS
02/29/2024 Sumitomo Pharma Co., Ltd. Latuda (Drug) Honoraria Cash or cash equivalent $755.68 General
Category: CNS
02/10/2024 Sumitomo Pharma Co., Ltd. Latuda (Drug) Travel and Lodging In-kind items and services $354.12 General
Category: CNS
02/09/2024 Sumitomo Pharma Co., Ltd. Latuda (Drug) Travel and Lodging In-kind items and services $410.86 General
Category: CNS
02/09/2024 Sumitomo Pharma Co., Ltd. Latuda (Drug) Travel and Lodging In-kind items and services $354.12 General
Category: CNS
02/09/2024 Sumitomo Pharma Co., Ltd. Latuda (Drug) Travel and Lodging In-kind items and services $230.92 General
Category: CNS
02/09/2024 Sumitomo Pharma Co., Ltd. Latuda (Drug) Food and Beverage In-kind items and services $0.91 General
Category: CNS
11/30/2023 Sumitomo Pharma Co., Ltd. Latuda (Drug) Consulting Fee Cash or cash equivalent $1,157.01 General
Category: CNS
10/20/2023 Sumitomo Pharma Co., Ltd. Latuda (Drug) Consulting Fee Cash or cash equivalent $1,139.99 General
Category: CNS
09/29/2023 Sumitomo Pharma Co., Ltd. Latuda (Drug) Consulting Fee Cash or cash equivalent $532.00 General
Category: CNS
08/18/2023 Sumitomo Pharma Co., Ltd. Latuda (Drug) Honoraria Cash or cash equivalent $782.68 General
Category: CNS
08/06/2023 Sumitomo Pharma Co., Ltd. Latuda (Drug) Travel and Lodging In-kind items and services $908.33 General
Category: CNS
08/06/2023 Sumitomo Pharma Co., Ltd. Latuda (Drug) Travel and Lodging In-kind items and services $303.39 General
Category: CNS
08/06/2023 Sumitomo Pharma Co., Ltd. Latuda (Drug) Travel and Lodging In-kind items and services $60.79 General
Category: CNS
08/06/2023 Sumitomo Pharma Co., Ltd. Latuda (Drug) Travel and Lodging In-kind items and services $54.65 General
Category: CNS
08/06/2023 Sumitomo Pharma Co., Ltd. Latuda (Drug) Food and Beverage In-kind items and services $17.44 General
Category: CNS
08/06/2023 Sumitomo Pharma Co., Ltd. Latuda (Drug) Travel and Lodging In-kind items and services $2.07 General
Category: CNS
07/19/2023 Sumitomo Pharma Co., Ltd. Honoraria Cash or cash equivalent $571.70 General
05/31/2023 Sumitomo Pharma Co., Ltd. Latuda (Drug) Consulting Fee Cash or cash equivalent $1,225.07 General
Category: CNS
02/28/2023 Sumitomo Pharma Co., Ltd. Latuda (Drug) Consulting Fee Cash or cash equivalent $1,242.08 General
Category: CNS
12/09/2022 Sumitomo Pharma Co., Ltd. Latuda (Drug) Honoraria Cash or cash equivalent $828.05 General
Category: CNS
11/30/2022 Sumitomo Pharma Co., Ltd. Latuda (Drug) Consulting Fee Cash or cash equivalent $1,225.07 General
Category: CNS

About Takuya Saito

Takuya Saito is a Child & Adolescent Psychiatry healthcare provider based in Suginami, TOKYO. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2015. The National Provider Identifier (NPI) number assigned to this provider is 1659762060.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Takuya Saito has received a total of $75,944 in payments from pharmaceutical and medical device companies, with $6,622 received in 2024. These payments were reported across 128 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($51,665).

Practice Information

  • Specialty Child & Adolescent Psychiatry
  • Location Suginami, TOKYO
  • Active Since 02/07/2015
  • Last Updated 02/07/2015
  • Taxonomy Code 2084P0804X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1659762060

Products in Payments

  • Latuda (Drug) $34,223
  • Blonanserin (Drug) $16,451
  • Blonanserin (Device) $6,154
  • Lonasen (Drug) $1,521
  • Dasotraline (Drug) $694.61

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.